The Mycoplasma hyopneumoniae protein Mhp274 elicits mucosal and systemic immune responses in mice by Mengqi Xie, Zhongshun Huang, Yun Zhang, Yujie Gan, Huiying Li, Dan Li, Honglei Ding

“…The bottleneck in the development of more effective vaccines for MPS is the stimulation of effective immune responses in the host. …”
Get full text

The mental health implication of mpox: Enhancing care with genetic insights by Ovinuchi Ejiohuo

“…Furthermore, genetic insights can inform the development of safer vaccines and early interventions, particularly for vulnerable populations. …”
Get full text

Technological Cooperation Networks at Bio-Manguinhos: the Role of Information and Communication Technologies by Lázaro Pereira de Oliveira, Claudio Pitassi, Antônio Augusto Gonçalves

“…This article identifies and discusses the contribution of information and communication technologies (ICTs) to the technological cooperation projects of Bio-Manguinhos, a pharmaceutical manufacturer that belongs to Osvaldo Cruz Foundation (FIOCRUZ), responsible for producing vaccines, reagents and biopharmaceuticals, with priority on meeting the needs of the Brazilian public health system. …”
Get full text

Streptococcal Infections of Fish by Roy Yanong, Ruth Francis-Floyd

“…Preventive measures emphasize maintaining optimal water quality, minimizing stress, and employing vaccines and immunostimulants. Additionally, the document addresses the zoonotic potential of Streptococcus iniae, highlighting the low risk to healthy individuals but cautioning immunocompromised persons. …”
Get full text

Streptococcal Infections of Fish by Roy Yanong, Ruth Francis-Floyd

“…Preventive measures emphasize maintaining optimal water quality, minimizing stress, and employing vaccines and immunostimulants. Additionally, the document addresses the zoonotic potential of Streptococcus iniae, highlighting the low risk to healthy individuals but cautioning immunocompromised persons. …”
Get full text

The power of health economics and outcomes research (HEOR) in making decisions that matter by Oscar Herrera Restrepo

“… Deciding on approving and granting market access to new medical technologies such as pharmaceutical products, vaccines, or medical devices is a multifactorial research problem. …”
Get full text

The power of health economics and outcomes research (HEOR) in making decisions that matter by Oscar Herrera Restrepo

“… Deciding on approving and granting market access to new medical technologies such as pharmaceutical products, vaccines, or medical devices is a multifactorial research problem. …”
Get full text

A review of COVID-19-related thrombosis and anticoagulation strategies specific to the Asian population by Kai Chin Poh, Victoria Yu Jia Tay, Sarah Huixin Lin, Huei Leng Chee, Suhitharan Thangavelautham

“…There is intensive research targeted at better understanding of the virus pathogenicity, development of effective treatment strategies and vaccines against COVID-19. It is increasingly being recognised that the pathogenicity of COVID-19 extends beyond the respiratory system. …”
Get full text

Anti-cancer immunotherapy-related cardiotoxicity: preventable and treatable by Wu Helena T., Hsu Vanessa, Win Shwe, Xing Yan

“…This review examines various immunotherapy types, such as immune checkpoint inhibitors, adoptive T-cell therapies, and cancer vaccines, highlighting their cardiovascular risks. …”
Get full text

Resurgence of Mumps among Lower Socioeconomic Class of Children in Ahmedabad: A Cross-sectional Study of 115 Cases in a Tertiary Care Center by Dipti V Patel, Zeel Patel, Snehal V Patel, Pooja Gandhi, Gayatri Parmar, Param S Patel

“…No patient was fully vaccinated for mumps. Out of the 15.6% (18 patients) admitted, two patients (1.7%) suffered from mumps complication of orchitis. …”
Get full text

The power of health economics and outcomes research (HEOR) in making decisions that matter by Oscar Herrera Restrepo

“… Deciding on approving and granting market access to new medical technologies such as pharmaceutical products, vaccines, or medical devices is a multifactorial research problem. …”
Get full text

AAV-based vectors for human diseases modeling in laboratory animals by Timur I. Aliev, Dmitry V. Yudkin

“…The development of therapeutic drugs and vaccines requires the availability of appropriate model animals that replicate the pathogenesis of human diseases. …”
Get full text

Comparison Of Bacillus anthracis Prepared Used Antigens As ‎Diagnostic kit Of Anthrax In Laboratoy Animals.‎ by Al- Jebouri A.J. ‎, Al- Khatib G.M.‎

“…A comparison was carried out among the prepared antigens using skin test in non- vaccinated guinea pigs which showed negative results. …”
Get full text

Canine circovirus: an emerging virus of dogs and wild canids by Farzad Beikpour, Arash Letafati, Zahra Ahmadi Fakhr, Nicoal Decaro, Sayed-Hamidreza Mozhgani

“…Prevention strategies are hindered by the lack of targeted vaccines and the virus's resilience in the environment. …”
Get full text

Enterovirus-like particles encapsidate RNA and exhibit decreased stability due to lack of maturation. by Louis Kuijpers, Evdokia-Anastasia Giannopoulou, Yuzhen Feng, Wouter van den Braak, Abbas Freydoonian, Ramon Ramlal, Hugo Meiring, Belén Solano, Wouter H Roos, Arjen J Jakobi, Leo A van der Pol, Nynke H Dekker

“…To counteract hand, foot, and mouth disease-causing viruses such as enterovirus A71 and coxsackievirus A6, virus-like particles (VLPs) have emerged as a leading contender for the development of a multivalent vaccine. However, VLPs have shown rapid conversion from a highly immunogenic state to a less immunogenic state and low particle integrity lifetimes compared to inactivated virus vaccines, thus raising concerns about their overall stability. …”
Get full text

Induced protein expression in Leptospira spp. and its application to CRISPR/Cas9 mutant generation by L. G. V. Fernandes, A. L. T. O. Nascimento, J. E. Nally

“…These newly controlled protein expression systems will advance studies on the basic biology and virulence of Leptospira, as well as facilitate knockout mutant generation for improved veterinary vaccines.…”
Get full text

Beyond immortality: Epstein–Barr virus and the intricate dance of programmed cell death in cancer development by Arezoo Esmaeili, Prankur Awasthi, Samira Tabaee

“…Furthermore, the insights gleaned from this review could catalyze the design of vaccines aimed at preventing EBV infection or curtailing its oncogenic impact. …”
Get full text

Characterization of environmental and clinical surveillance inputs to support prospective integrated modeling of the polio endgame. by Kamran Badizadegan, Kimberly M Thompson

“…Relatively recently, the GPLN expanded to include environmental surveillance to obtain additional information about poliovirus transmission in some geographies and to increase confidence about the absence of poliovirus transmission after successful eradication and/or the cessation of use of live-attenuated oral poliovirus vaccines (OPVs). Historical polio eradication strategic plans anticipated that successful global poliovirus eradication would lead to reduced requirements for financial investments for a poliovirus-specific surveillance system, and consequent transition of capacity and resources into integrated national disease surveillance systems. …”
Get full text